S.‐O. Olofsson

3.7k total citations · 1 hit paper
41 papers, 3.1k citations indexed

About

S.‐O. Olofsson is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, S.‐O. Olofsson has authored 41 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 14 papers in Molecular Biology and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in S.‐O. Olofsson's work include Lipoproteins and Cardiovascular Health (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Cancer, Lipids, and Metabolism (9 papers). S.‐O. Olofsson is often cited by papers focused on Lipoproteins and Cardiovascular Health (14 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers) and Cancer, Lipids, and Metabolism (9 papers). S.‐O. Olofsson collaborates with scholars based in Sweden, Australia and Finland. S.‐O. Olofsson's co-authors include Jan Borén, Olov Wiklund, M Wettesten, Göran Bondjers, Marja‐Riitta Taskinen, Sabina Rustaeus, A Sjöberg, Peter Carlsson, Göran Bondjers and Kristina Bengtsson Boström and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Biochemistry.

In The Last Decade

S.‐O. Olofsson

40 papers receiving 3.0k citations

Hit Papers

Overproduction of large VLDL particles is driven by incre... 2006 2026 2012 2019 2006 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S.‐O. Olofsson Sweden 24 1.1k 989 797 784 717 41 3.1k
Ewa Ninio France 37 570 0.5× 1.4k 1.4× 1.2k 1.4× 576 0.7× 748 1.0× 103 4.1k
Ross W. Milne Canada 33 934 0.8× 1.2k 1.3× 938 1.2× 388 0.5× 414 0.6× 69 3.2k
Jayme Borensztajn United States 30 882 0.8× 1.1k 1.1× 723 0.9× 601 0.8× 718 1.0× 65 3.1k
Norbert Katz Germany 35 484 0.4× 1.2k 1.2× 684 0.9× 541 0.7× 564 0.8× 72 3.3k
B H Chung United States 31 1.1k 0.9× 1.1k 1.2× 1.1k 1.3× 498 0.6× 636 0.9× 52 3.4k
Eva Hurt‐Camejo Sweden 42 843 0.8× 1.8k 1.8× 1.5k 1.9× 623 0.8× 793 1.1× 92 4.8k
Naohiko Sakai Japan 37 1.8k 1.6× 1.2k 1.3× 2.2k 2.8× 1.1k 1.4× 1.2k 1.7× 90 4.8k
Ronald Barbaras France 30 1.2k 1.0× 1.2k 1.2× 1.4k 1.8× 351 0.4× 508 0.7× 53 3.4k
E L Bierman United States 32 1.6k 1.5× 1.5k 1.5× 2.0k 2.5× 750 1.0× 566 0.8× 76 4.4k
Kazuhisa Tsukamoto Japan 30 723 0.6× 1.6k 1.6× 960 1.2× 313 0.4× 911 1.3× 103 3.5k

Countries citing papers authored by S.‐O. Olofsson

Since Specialization
Citations

This map shows the geographic impact of S.‐O. Olofsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S.‐O. Olofsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S.‐O. Olofsson more than expected).

Fields of papers citing papers by S.‐O. Olofsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S.‐O. Olofsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S.‐O. Olofsson. The network helps show where S.‐O. Olofsson may publish in the future.

Co-authorship network of co-authors of S.‐O. Olofsson

This figure shows the co-authorship network connecting the top 25 collaborators of S.‐O. Olofsson. A scholar is included among the top collaborators of S.‐O. Olofsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S.‐O. Olofsson. S.‐O. Olofsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Olofsson, S.‐O., et al.. (2025). Patient participation in self-monitoring regarding healthcare of heart failure: an integrated systematic review. BMC Primary Care. 26(1). 60–60. 2 indexed citations
3.
Nystrôm, Kristina, Rickard Nordén, Isabella Muylaert, et al.. (2009). Induction of sialyl-Lex expression by herpes simplex virus type 1 is dependent on viral immediate early RNA-activated transcription of host fucosyltransferase genes. Glycobiology. 19(8). 847–859. 17 indexed citations
4.
Kempf, Tibor, E. Bjorklund, S.‐O. Olofsson, et al.. (2007). Growth-differentiation factor-15 improves risk stratification in ST-segment elevation myocardial infarction. European Heart Journal. 28(23). 2858–2865. 189 indexed citations
5.
Adiels, Martin, Marja‐Riitta Taskinen, Chris J. Packard, et al.. (2006). Overproduction of large VLDL particles is driven by increased liver fat content in man. Diabetologia. 49(4). 755–765. 537 indexed citations breakdown →
6.
Henning, Petra, Ophélia Granio, Per‐Åke Nygren, et al.. (2006). Decreased immune reactivity towards a knobless, affibody-targeted adenovirus type 5 vector. Gene Therapy. 14(4). 376–381. 23 indexed citations
7.
Olofsson, S.‐O. & Jan Borén. (2005). Apolipoprotein B: a clinically important apolipoprotein which assembles atherogenic lipoproteins and promotes the development of atherosclerosis. Journal of Internal Medicine. 258(5). 395–410. 248 indexed citations
8.
Borén, Jan, Maria Andersson, Thomas Larsson, et al.. (1999). The assembly and secretion of apo-B48 containing lipoproteins in McA-RH7777 cells. Atherosclerosis. 144. 4–4. 1 indexed citations
9.
Sjöberg, A, Jan Oscarsson, S.‐O. Olofsson, & S Edén. (1994). Insulin-like growth factor-I and growth hormone have different effects on serum lipoproteins and secretion of lipoproteins from cultured rat hepatocytes.. Endocrinology. 135(4). 1415–1421. 30 indexed citations
10.
Berglund, Lars, Olov Wiklund, Gösta Eggertsen, et al.. (1993). Apolipoprotein E phenotypes in familial hypercholesterolaemia: importance for expression of disease and response to therapy. Journal of Internal Medicine. 233(2). 173–178. 44 indexed citations
11.
Sjöberg, A, Jan Oscarsson, Kristina Bengtsson Boström, et al.. (1992). Effects of growth hormone on apolipoprotein-B (apoB) messenger ribonucleic acid editing, and apoB 48 and apoB 100 synthesis and secretion in the rat liver.. Endocrinology. 130(6). 3356–3364. 54 indexed citations
12.
Borén, Jan, Laurie A. Graham, M Wettesten, et al.. (1992). The assembly and secretion of ApoB 100-containing lipoproteins in Hep G2 cells. ApoB 100 is cotranslationally integrated into lipoproteins.. Journal of Biological Chemistry. 267(14). 9858–9867. 159 indexed citations
13.
Bolmstedt, Anders, Per Flodby, Bruce Travis, et al.. (1991). Effects of mutations in glycosylation sites and disulphide bonds on processing, CD4-binding and fusion activity of human immunodeficiency virus envelope glycoproteins. Journal of General Virology. 72(6). 1269–1277. 40 indexed citations
14.
Olofsson, S.‐O., et al.. (1991). Selective Induction of Discrete Epitopes of Herpes Simplex Virus Type 1-Specified Glycoprotein C by Interference with Terminal Steps in Glycosylation. Journal of General Virology. 72(8). 1959–1965. 6 indexed citations
15.
Wiklund, O., Bo Angelin, Gunnar Fager, et al.. (1990). Treatment of familial hypercholesterolaemia: a controlled trial of the effects of pravastatin or cholestyramine therapy on lipoprotein and apolipoprotein levels. Journal of Internal Medicine. 228(3). 241–247. 38 indexed citations
16.
Borén, Jan, M Wettesten, A Sjöberg, et al.. (1990). The assembly and secretion of apoB 100 containing lipoproteins in Hep G2 cells. Evidence for different sites for protein synthesis and lipoprotein assembly.. Journal of Biological Chemistry. 265(18). 10556–10564. 121 indexed citations
17.
Wiklund, Olov, Catarina Darnfors, Gunnar Bjursell, et al.. (1989). Xbal restriction fragment length polymorphism of apolipoprotein B in Swedish myocardial infarction patients. European Journal of Clinical Investigation. 19(3). 255–258. 20 indexed citations
18.
Bondjers, Göran, T. LINDÉN, Gunnar Fager, et al.. (1988). Aortic intimal lipid content and serum lipoproteins in patients undergoing coronary by-pass surgery as related to clinical prognosis. Atherosclerosis. 72(2-3). 231–239. 5 indexed citations
19.
Carlsson, Peter, S.‐O. Olofsson, Göran Bondjers, et al.. (1985). Molecular cloning of human apolipoprotein B cDNA. Nucleic Acids Research. 13(24). 8813–8826. 44 indexed citations
20.
Olofsson, S.‐O., Gunnar Fager, & A. Gustafson. (1976). Studies on Human Serum High-Density Lipoproteins: VI. Studies on a Cholesterol Ester-Releasing Reaction in Vitro. Scandinavian Journal of Clinical and Laboratory Investigation. 36(5). 481–488. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026